Intervention not reported
GBR830 (1 RCT; 46 participants) · patients with moderate to severe eczema
The intervention showed no clear difference in GBR830 (1 RCT; 46 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Azathiopine (AZA) (1 RCT; 41 participants) · patients with moderate to severe eczema
The intervention showed no clear difference in azathiopine (AZA) (1 RCT; 41 participants) (low certainty).
1 finding from 1 review
Intervention not reported
QAW039 (1 RCT; 76 participants) · patients with moderate to severe eczema
It is very uncertain whether the intervention changes QAW039 (1 RCT; 76 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
CsAI (1 RCT; 40 participants) · patients with moderate to severe eczema
It is very uncertain whether the intervention changes csAI (1 RCT; 40 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Placebo · patients with moderate to severe eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Dupilumab (5 RCTs; 1997 participants) · patients with moderate to severe eczema
1 finding from 1 review
Intervention not reported
Placebo · patients with moderate to severe eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Total studies: 17 RCTsTotal participants: 3972 · patients with moderate to severe eczema
1 finding from 1 review
Intervention not reported
QAW039 (1 RCT; 76 participants) · patients with moderate to severe eczema
The intervention probably leads to lower QAW039 (1 RCT; 76 participants) (moderate certainty).
1 finding from 1 review
Intervention not reported
Dupilumab (9 RCTs; 1663 participants) · patients with moderate to severe eczema
The intervention may leads to lower dupilumab (9 RCTs; 1663 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Timapiprant (1 RCT; 70 participants) · patients with moderate to severe eczema
The intervention showed no clear difference in timapiprant (1 RCT; 70 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Supportive care only*** (1 RCT, 81 participants) · elderly people with newly diagnosed glioblastoma Interventions: radiotherapy with 40 Gy in 15 fractions (RT40); radiotherapy with 60 Gy in…
1 finding from 1 review
Intervention not reported
TMZ (3 RCTs, 538 participants) · elderly people with newly diagnosed glioblastoma Interventions: chemoradiotherapy (CRT); chemoradiotherapy plus bevacizumab (BEV_CRT);…
The intervention showed no clear difference in TMZ (3 RCTs, 538 participants) (low certainty).
1 finding from 1 review
Intervention not reported
CRT (2 RCTs; 635 participants) · elderly people with newly diagnosed glioblastoma Interventions: chemoradiotherapy (CRT); chemoradiotherapy plus bevacizumab (BEV_CRT);…
The intervention leads to lower CRT (2 RCTs; 635 participants) (high certainty).
1 finding from 1 review
Intervention not reported
BEV_CRT (1 RCT; 73 participants) · elderly people with newly diagnosed glioblastoma Interventions: chemoradiotherapy (CRT); chemoradiotherapy plus bevacizumab (BEV_CRT);…
The intervention probably leads to lower BEV_CRT (1 RCT; 73 participants) (moderate certainty).
1 finding from 1 review
Intervention not reported
RT 60 (5 RCTs; 713 participants) · elderly people with newly diagnosed glioblastoma Interventions: radiotherapy with 40 Gy in 15 fractions (RT 40); chemoradiotherapy (CRT);…
1 finding from 1 review
Intervention not reported
RT 40 (4 RCTs; 930 participants) · elderly people with newly diagnosed glioblastoma Interventions: radiotherapy with 40 Gy in 15 fractions (RT 40); chemoradiotherapy (CRT);…
The intervention showed no clear difference in RT 40 (4 RCTs; 930 participants) (low certainty).
1 finding from 1 review
Intervention not reported
BEV_RT (1 RCT; 75 participants) · elderly people with newly diagnosed glioblastoma Interventions: radiotherapy with 40 Gy in 15 fractions (RT 40); chemoradiotherapy (CRT);…
It is very uncertain whether the intervention changes BEV_RT (1 RCT; 75 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
TMZ (3 RCTs, 538 participants) · elderly people with newly diagnosed glioblastoma Interventions: radiotherapy with 40 Gy in 15 fractions (RT 40); chemoradiotherapy (CRT);…
It is very uncertain whether the intervention changes TMZ (3 RCTs, 538 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
CRT (2 RCTs; 635 participants) · elderly people with newly diagnosed glioblastoma Interventions: radiotherapy with 40 Gy in 15 fractions (RT 40); chemoradiotherapy (CRT);…
The intervention may leads to lower CRT (2 RCTs; 635 participants) (low certainty).
1 finding from 1 review